Pre-Clinical Equipment Supplied In Africa

Innovation is at the heart of everything we do. Our proprietary drug delivery technology platform, Veltis®, uses engineered recombinant albumin to enhance albumin’s intrinsic characteristics for optimal therapeutic performance of your ...

Baker Ruskinn's SCI-tive Dual hypoxia workstation allows you to work with two independently controlled atmospheres for cell culture under physiological oxygen. As with the single SCI-tive hypoxia workstation, SCI-tive Dual's closed cell culture environment mimics in vivo conditions with precise, user-defined controls, allowing you study even the most complex cell interactions. The spacious ...

The OptiShuntV2 is the follow-on device which incorporates design optimisation changes and is set for clinical trials kicking off in January 2022. The device includes a two-part construction and an upgraded shunt insertion system to make the device simpler, safer, and even more ...

The OptiShuntV1 is a proof of concept device designed to evaluate the safety, feasibility, and efficacy of patented technology for the treatment of glaucoma. The device is manufactured using world-class silicone micro moulding techniques according to ISO13485 guidelines and includes a custom shunt insertion system. Clinical trials are currently underway in the GOSSIP study being conducted at ...

Designed for the emerging market of preclinical and molecular MR imaging: The BioSpec series is designed for the emerging market of preclinical and molecular MR imaging. State-of-the-art MRI CryoProbe technology together with ultra high field USR magnets deliver high spatial resolution in vivo enabling customers to come closer to the molecular and cellular level research they desire. Thanks to ...